Here are four biologics updates Becker's has reported on since Dec. 13:
1. RTI Surgical signed an agreement to acquire Cook Biotech.
2. Kuros Biosciences hit three advancements for its MagnetOS portfolio.
3. Ossium Health's OssiGraft viable bone matrix allograft was used in its first patient case.
4. Legislation has been introduced in the U.S. House that would require all bone graft material to be tested for active and latent tuberculosis. It would also expedite the process for developing a screening test.